Zonisamide is a 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position. Among its listed roles, it functions as a anticonvulsant, an antioxidant, a central nervous system drug, a protective agent and a T-type calcium channel blocker. It belongs to the class of 1,2-benzoxazoles and a sulfonamide. It is also used off-label for various other seizure types and Parkinson’s disease. It is grouped under the following drug class(es): Neurotransmitter agents. Its therapeutic use is listed as alcohol dependence agents, anti-epileptic drugs, anticonvulsants, antiparkinsonian agents and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Zonegran and Zonisade. Its PubChem CID is 5734.
Zonisamide
| CAS No | 68291-97-4 |
|---|---|
| Molecular Formula | C8H8N2O3S |
| Molecular Weight | 212.23 g/mol |
| Synonyms | 1,2-benzoxazol-3-ylmethanesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Zonisamide is a 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position. Among its listed roles, it functions as a anticonvulsant, an antioxidant, a central nervous system drug, a protective agent and a T-type calcium channel blocker.
The listed CAS number is 68291-97-4.
The listed molecular formula is C8H8N2O3S.
The listed molecular weight is 212.23 g/mol.
1,2-benzoxazol-3-ylmethanesulfonamide.
The source lists Zonegran and Zonisade.